Societal costs of untreated perinatal mood and anxiety disorders in Vermont
- PMID: 38321244
- DOI: 10.1007/s00737-024-01429-1
Societal costs of untreated perinatal mood and anxiety disorders in Vermont
Abstract
Purpose: To estimate the societal costs of untreated perinatal mood and anxiety disorders (PMADs) in Vermont for the 2018-2020 average annual birth cohort from conception through five years postpartum.
Methods: We developed a cost analysis model to calculate the excess cases of outcomes attributed to PMADs in the state of Vermont. Then, we modeled the associated costs of each outcome incurred by birthing parents and their children, projected five years for birthing parents who do not achieve remission by the end of the first year postpartum.
Results: We estimated that the total societal cost of untreated PMADs in Vermont could reach $48 million for an annual birth cohort from conception to five years postpartum, amounting to $35,910 in excess societal costs per birthing parent with an untreated PMAD and their child.
Conclusion: Our model provides evidence of the high costs of untreated PMADs for birthing parents and their children in Vermont. Our estimates for Vermont are slightly higher but comparable to national estimates, which are $35,500 per birthing parent-child pair, adjusted to 2021 US dollars. Investing in perinatal mental health prevention and treatment could improve health outcomes and reduce economic burden of PMADs on individuals, families, employers, and the state.
Keywords: Cost analysis; Health economics; Maternal health; PMADs; Perinatal mental health.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
References
-
- Adane AA, Bailey HD, Morgan VA et al (2021) The impact of maternal prenatal mental health disorders on stillbirth and infant mortality: a systematic review and meta-analysis. Arch Womens Ment Health 24:543–555. https://doi.org/10.1007/s00737-020-01099-9 - DOI - PubMed
-
- Adhikari K, Pattern S, Lee S, Metcalfe A (2019) Risk of adverse perinatal outcomes among women with pharmacologically treated and untreated depression during pregnancy: A retrospective cohort study. Paediatr Perinat Epidemiol 33:323–331. https://doi.org/10.1111/ppe.12576 - DOI - PubMed
-
- Ammerman RT, Chen J, Mallow PJ et al (2016) Annual direct health care expenditures and employee absenteeism costs in high-risk, low-income mothers with major depression. J Affect Disord 190:386–394. https://doi.org/10.1016/j.jad.2015.10.025 - DOI - PubMed
-
- Ananth CV, Keyes KM, Wapner RJ (2013) Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ 347:f6564. https://doi.org/10.1136/bmj.f6564 - DOI - PubMed - PMC
-
- Bansil P, Kuklina EV, Meikle SF et al (2010) Maternal and fetal outcomes among women with depression. J Womens Health 2002 19:329–334. https://doi.org/10.1089/jwh.2009.1387 - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical